Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli

NG-Test CARBA 5 (NG-Biotech) is a rapid in vitro multiplex immunoassay for the phenotypic detection and differentiation of the "big five" carbapenemase families (KPC, OXA-48-like, VIM, IMP, and NDM). Version 2 of this assay was evaluated alongside the Xpert Carba-R assay (Cepheid, Inc.), t...

Full description

Saved in:
Bibliographic Details
Main Authors: Khoo, Bo Yan, Hon, Pei Yun, Leong, Janice, Sridatta, Prakki Sai Rama, Thevasagayam, Natascha May, Loy, Dennis Song Qi, Chua, Jasmine J. Y., Ang, Brenda Sze Peng, Chow, Angela, Marimuthu, Kalisvar, De, Partha Pratim, Ng, Oon Tek, Vasoo, Shawn
Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
Format: Article
Language:English
Published: 2023
Subjects:
Online Access:https://hdl.handle.net/10356/171589
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-171589
record_format dspace
spelling sg-ntu-dr.10356-1715892023-11-05T15:39:50Z Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli Khoo, Bo Yan Hon, Pei Yun Leong, Janice Sridatta, Prakki Sai Rama Thevasagayam, Natascha May Loy, Dennis Song Qi Chua, Jasmine J. Y. Ang, Brenda Sze Peng Chow, Angela Marimuthu, Kalisvar De, Partha Pratim Ng, Oon Tek Vasoo, Shawn Lee Kong Chian School of Medicine (LKCMedicine) National Centre for Infectious Diseases Tan Tock Seng Hospital Yong Loo Lin School of Medicine, NUS Saw Swee Hock School of Public Health, NUS Science::Medicine NG-Test CARBA 5 Xpert Carba-R NG-Test CARBA 5 (NG-Biotech) is a rapid in vitro multiplex immunoassay for the phenotypic detection and differentiation of the "big five" carbapenemase families (KPC, OXA-48-like, VIM, IMP, and NDM). Version 2 of this assay was evaluated alongside the Xpert Carba-R assay (Cepheid, Inc.), the modified carbapenem inactivation method (mCIM), and the CIMTris assay, with a collection of carbapenem-resistant non-fermenting Gram-negative bacilli comprising 138 Pseudomonas aeruginosa and 97 Acinetobacter baumannii isolates. Whole-genome sequencing (WGS) was used as the reference standard. For P. aeruginosa, NG-Test CARBA 5 produced an overall percentage agreement (OPA) with WGS of 97.1%, compared with 92.8% forXpert Carba-R and 90.6% for mCIM. For A. baumannii, as OXA-type carbapenemases (non-OXA-48) are not included, both the NG-Test CARBA 5 and Xpert Carba-R only had an OPA of 6.2%, while the CIMTris performed well with an OPA of 99.0%. The majority of A. baumannii isolates (95.9%) tested falsely positive for IMP on NG-Test CARBA 5; no IMP genes were found on WGS. No clear cause was found for this phenomenon; a cross-reacting protein antigen unique to A. baumannii is a possible culprit. NG-Test CARBA 5 performed well for carbapenemase detection in P. aeruginosa. However, results from A. baumannii isolates should be interpreted with caution. Ministry of Health (MOH) National Medical Research Council (NMRC) Published version This work was supported by the Ministry of Health, Singapore, under the FY16 Health Service Development Programme (HSDP) Project 19N01: "Reducing the spread of carbapenemase producing Gram-negative bacteria via rapid and direct detection from surveillance and clinical samples" (S.V.), as well as the National Medical Research Council (NMRC) Centre Grant: “Collaborative Solutions Targeting Antimicrobial Resistance Threats in Health Systems (CoSTAR-HS)" (CG21APR2005), NMRC Clinician Scientist Award (MOH-000276), NMRC Open Fund—Large Collaborative Grant: AntiMicrobial resistance Research & Intervention Alliance Singapore (AMRITAS; MOH-001326-01) (O.T.N.), and NMRC Clinician Scientist Individual Research Grant (CIRG18Nov-0034) (K.M.). 2023-10-31T08:01:01Z 2023-10-31T08:01:01Z 2023 Journal Article Khoo, B. Y., Hon, P. Y., Leong, J., Sridatta, P. S. R., Thevasagayam, N. M., Loy, D. S. Q., Chua, J. J. Y., Ang, B. S. P., Chow, A., Marimuthu, K., De, P. P., Ng, O. T. & Vasoo, S. (2023). Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli. Journal of Clinical Microbiology, 61(9), e0031623-. https://dx.doi.org/10.1128/jcm.00316-23 0095-1137 https://hdl.handle.net/10356/171589 10.1128/jcm.00316-23 37671882 2-s2.0-85171901878 9 61 e0031623 en 19N01 CG21APR2005 MOH-000276 MOH-001326-01 Journal of Clinical Microbiology © 2023 American Society for Microbiology. All Rights Reserved. This article may be downloaded for personal use only. Any other use requires prior permission of the copyright holder. The Version of Record is available online at http://doi.org/10.1128/jcm.00316-23 application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Science::Medicine
NG-Test CARBA 5
Xpert Carba-R
spellingShingle Science::Medicine
NG-Test CARBA 5
Xpert Carba-R
Khoo, Bo Yan
Hon, Pei Yun
Leong, Janice
Sridatta, Prakki Sai Rama
Thevasagayam, Natascha May
Loy, Dennis Song Qi
Chua, Jasmine J. Y.
Ang, Brenda Sze Peng
Chow, Angela
Marimuthu, Kalisvar
De, Partha Pratim
Ng, Oon Tek
Vasoo, Shawn
Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
description NG-Test CARBA 5 (NG-Biotech) is a rapid in vitro multiplex immunoassay for the phenotypic detection and differentiation of the "big five" carbapenemase families (KPC, OXA-48-like, VIM, IMP, and NDM). Version 2 of this assay was evaluated alongside the Xpert Carba-R assay (Cepheid, Inc.), the modified carbapenem inactivation method (mCIM), and the CIMTris assay, with a collection of carbapenem-resistant non-fermenting Gram-negative bacilli comprising 138 Pseudomonas aeruginosa and 97 Acinetobacter baumannii isolates. Whole-genome sequencing (WGS) was used as the reference standard. For P. aeruginosa, NG-Test CARBA 5 produced an overall percentage agreement (OPA) with WGS of 97.1%, compared with 92.8% forXpert Carba-R and 90.6% for mCIM. For A. baumannii, as OXA-type carbapenemases (non-OXA-48) are not included, both the NG-Test CARBA 5 and Xpert Carba-R only had an OPA of 6.2%, while the CIMTris performed well with an OPA of 99.0%. The majority of A. baumannii isolates (95.9%) tested falsely positive for IMP on NG-Test CARBA 5; no IMP genes were found on WGS. No clear cause was found for this phenomenon; a cross-reacting protein antigen unique to A. baumannii is a possible culprit. NG-Test CARBA 5 performed well for carbapenemase detection in P. aeruginosa. However, results from A. baumannii isolates should be interpreted with caution.
author2 Lee Kong Chian School of Medicine (LKCMedicine)
author_facet Lee Kong Chian School of Medicine (LKCMedicine)
Khoo, Bo Yan
Hon, Pei Yun
Leong, Janice
Sridatta, Prakki Sai Rama
Thevasagayam, Natascha May
Loy, Dennis Song Qi
Chua, Jasmine J. Y.
Ang, Brenda Sze Peng
Chow, Angela
Marimuthu, Kalisvar
De, Partha Pratim
Ng, Oon Tek
Vasoo, Shawn
format Article
author Khoo, Bo Yan
Hon, Pei Yun
Leong, Janice
Sridatta, Prakki Sai Rama
Thevasagayam, Natascha May
Loy, Dennis Song Qi
Chua, Jasmine J. Y.
Ang, Brenda Sze Peng
Chow, Angela
Marimuthu, Kalisvar
De, Partha Pratim
Ng, Oon Tek
Vasoo, Shawn
author_sort Khoo, Bo Yan
title Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
title_short Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
title_full Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
title_fullStr Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
title_full_unstemmed Evaluation of NG-Test CARBA 5 version 2, Cepheid Xpert Carba-R, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting Gram-negative bacilli
title_sort evaluation of ng-test carba 5 version 2, cepheid xpert carba-r, and carbapenem inactivation methods in comparison to whole-genome sequencing for the identification of carbapenemases in non-fermenting gram-negative bacilli
publishDate 2023
url https://hdl.handle.net/10356/171589
_version_ 1783955606549299200